PriceTargets.com logo

Extendicare - EXE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$23.86
  • Forecasted Upside: 8.05%
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 3 Strong Buy Ratings
C$22.08 As of 12/4/2025 05:00 PM ET
▲ +1.09 (5.19%)

This chart shows the closing price for EXE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Extendicare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EXE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EXE

Analyst Price Target is C$23.86
▲ +8.05% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Extendicare in the last 3 months. The average price target is C$23.86, with a high forecast of C$30.00 and a low forecast of C$19.00. The average price target represents a 8.05% upside from the last price of C$22.08.

This chart shows the closing price for EXE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 8 investment analysts is to buy stock in Extendicare. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 2 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 3 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 3 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/4/2025BMO Capital MarketsUpgradeMarket Perform ➝ OutperformC$21.00 ➝ C$24.00
12/4/2025Canaccord Genuity GroupBoost TargetC$20.00 ➝ C$22.50
12/4/2025Royal Bank Of CanadaUpgradeSector Perform ➝ OutperformC$15.00 ➝ C$25.00
12/3/2025Natl Bk CanadaUpgradeStrong-Buy
12/3/2025CormarkBoost TargetC$25.00 ➝ C$30.00
12/3/2025National BanksharesBoost TargetOutperformC$21.50 ➝ C$24.50
11/17/2025BMO Capital MarketsBoost TargetC$15.00 ➝ C$21.00
11/13/2025CIBCBoost TargetC$18.00 ➝ C$22.00
11/13/2025TD SecuritiesBoost TargetC$15.00 ➝ C$19.00
10/8/2025National BanksharesBoost TargetOutperformC$16.10 ➝ C$17.50
9/22/2025Cibc World MktsUpgradeStrong-Buy
9/22/2025CIBCSet TargetOutperformC$18.00
8/8/2025National BanksharesBoost TargetOutperformC$15.45 ➝ C$16.10
7/17/2025National BanksharesSet TargetOutperformC$15.40
7/16/2025National Bank FinancialUpgradeStrong-Buy
5/22/2025TD SecuritiesBoost TargetHoldC$13.00 ➝ C$15.00
5/12/2025BMO Capital MarketsBoost TargetC$13.50 ➝ C$14.50
3/3/2025TD SecuritiesBoost TargetHoldC$10.50 ➝ C$13.00
3/3/2025BMO Capital MarketsBoost TargetC$11.00 ➝ C$13.50
2/19/2025CormarkUpgradeModerate Buy
1/30/2025BMO Capital MarketsSet TargetMarket PerformC$11.00
1/28/2025BMO Capital MarketsUpgradeHold
11/28/2024Royal Bank Of CanadaBoost TargetSector PerformC$9.50 ➝ C$11.00
11/14/2024TD SecuritiesBoost TargetHoldC$9.50 ➝ C$10.50
9/4/2024TD SecuritiesBoost TargetHoldC$9.00 ➝ C$9.50
8/19/2024Royal Bank Of CanadaBoost TargetC$8.50 ➝ C$9.50
8/14/2024TD SecuritiesBoost TargetHoldC$8.00 ➝ C$9.00
5/21/2024Royal Bank Of CanadaBoost TargetSector PerformC$8.00 ➝ C$8.50
5/17/2024TD SecuritiesBoost TargetHoldC$7.50 ➝ C$8.00
3/11/2024Leede Jones GableBoost TargetBuyC$7.00 ➝ C$8.50
3/11/2024TD SecuritiesBoost TargetHoldC$7.00 ➝ C$7.50
3/11/2024Royal Bank Of CanadaBoost TargetSector PerformC$7.50 ➝ C$8.00
11/13/2023Leede Jones GabUpgradeHold ➝ Buy
5/9/2023Royal Bank Of CanadaBoost TargetSector PerformC$7.00 ➝ C$7.50
5/9/2023National BanksharesBoost TargetSector PerformC$7.00 ➝ C$7.50
3/6/2023Royal Bank Of CanadaLower TargetSector PerformC$7.50 ➝ C$7.00
1/30/2023National BanksharesLower TargetSector PerformC$7.50 ➝ C$7.00
11/17/2022Royal Bank Of CanadaLower TargetSector PerformC$8.00 ➝ C$7.50
10/24/2022National BanksharesLower TargetC$8.00 ➝ C$7.50
10/20/2022TD SecuritiesLower TargetHoldC$7.50 ➝ C$7.00
6/27/2022CIBCLower TargetC$8.50 ➝ C$8.00
3/3/2022Royal Bank Of CanadaBoost TargetSector PerformC$8.00 ➝ C$8.50
2/28/2022CIBCBoost TargetNeutralC$8.25 ➝ C$8.50
2/7/2022TD SecuritiesReiterated RatingHoldC$8.00
11/15/2021Royal Bank Of CanadaLower TargetSector PerformC$8.50 ➝ C$8.00
11/9/2021Laurentian Bank of CanadaReiterated RatingHold
11/8/2021Laurentian Bank of CanadaLower TargetC$8.00
11/8/2021TD SecuritiesLower TargetHoldC$8.50 ➝ C$8.00
11/8/2021LaurentianLower TargetC$8.75 ➝ C$8.00
11/1/2021CIBCReiterated RatingNeutralC$8.25
8/9/2021Laurentian Bank of CanadaBoost TargetC$8.25 ➝ C$8.75
8/9/2021LaurentianBoost TargetC$8.25 ➝ C$8.75
7/19/2021National BanksharesBoost TargetC$8.50 ➝ C$9.00
7/19/2021National Bank FinancialBoost TargetNAC$9.00
5/21/2021Royal Bank Of CanadaBoost TargetSector PerformC$7.00 ➝ C$8.50
5/18/2021Laurentian Bank of CanadaBoost TargetHoldC$8.25
5/18/2021LaurentianBoost TargetC$7.00 ➝ C$8.25
5/17/2021National Bank FinancialBoost TargetNAC$8.50
5/17/2021National BanksharesBoost TargetSector PerformC$8.00 ➝ C$8.50
5/14/2021TD SecuritiesBoost TargetHoldC$7.00 ➝ C$8.00
3/1/2021Leede Jones GabReiterated RatingBuy
3/1/2021National Bank FinancialReiterated RatingSector PerformC$6.50 ➝ C$7.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 8 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 8 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Extendicare logo
Extendicare Inc., operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Read More

Today's Range

Now: C$22.08
Low: C$21.36
High: C$22.57

50 Day Range

MA: C$17.14
Low: C$14.60
High: C$22.08

52 Week Range

Now: C$22.08
Low: C$9.69
High: C$22.57

Volume

610,304 shs

Average Volume

193,559 shs

Market Capitalization

C$1.85 billion

P/E Ratio

20.83

Dividend Yield

2.45%

Beta

0.90071

Frequently Asked Questions

What sell-side analysts currently cover shares of Extendicare?

The following equities research analysts have issued research reports on Extendicare in the last year: BMO Capital Markets, Canaccord Genuity Group Inc., CIBC, Cibc World Mkts, Cormark, National Bank Financial, National Bankshares, Inc., Natl Bk Canada, Royal Bank Of Canada, and TD Securities.
View the latest analyst ratings for EXE.

What is the current price target for Extendicare?

0 Wall Street analysts have set twelve-month price targets for Extendicare in the last year. Their average twelve-month price target is C$23.86, suggesting a possible upside of 7.4%. Cormark has the highest price target set, predicting EXE will reach C$30.00 in the next twelve months. TD Securities has the lowest price target set, forecasting a price of C$19.00 for Extendicare in the next year.
View the latest price targets for EXE.

What is the current consensus analyst rating for Extendicare?

Extendicare currently has 1 hold rating, 4 buy ratings and 3 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EXE will outperform the market and that investors should add to their positions of Extendicare.
View the latest ratings for EXE.

What other companies compete with Extendicare?

Other companies that are similar to Extendicare include dentalcorp, Sienna Senior Living, WELL Health Technologies, Medical Facilities and KDA Group. Learn More about companies similar to Extendicare.

How do I contact Extendicare's investor relations team?

Extendicare's physical mailing address is 3000 Steeles Avenue East, Suite 700, Markham, ON L3R 4T9, Canada. The company's listed phone number is 905-470-4000. The official website for Extendicare is www.extendicare.com. Learn More about contacing Extendicare investor relations.